Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine
Terry Nolan, Maria Elena Santolaya, Ferdinandus de Looze, Helen Marshall, Peter Richmond, Sam Henein, Paul Rheault, Ken Heaton, Kirsten P Perrett, Hartley Garfield, Anil Gupta, Murdo Ferguson, Diego D'Agostino, Daniela Toneatto, Miguel O'Ryan
Vaccine | ELSEVIER SCI LTD | Published : 2019
This study was funded by Novartis Vaccines and Diagnostics Inc., now part of the GSK group of companies. GlaxoSmithKline Biologicals SA took responsibility for all costs associated with the development and publishing of the present manuscript.